Effects of corticotropin-releasing hormone on proopiomelanocortin derivatives and monocytic HLA-DR expression in patients with septic shock

•Corticotropin-releasing hormone up-regulates monocytic HLA-DR (mHLA-DR) expression.•Proopiomelanocortin peptides do not up-regulate mHLA-DR expression.•α-MSH, an anti-inflammatory peptide, is also released by monocytes.•The loss of mHLA-DR expression correlates with the loss of monocytic α-MSH rele...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Peptides (New York, N.Y. : 1980) N.Y. : 1980), 2013-09, Vol.47, p.133-141
Hauptverfasser: Matejec, Reginald, Kayser, Friederike, Schmal, Frauke, Uhle, Florian, Bödeker, Rolf-Hasso, Maxeiner, Hagen, Kolbe, Julia Anna
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:•Corticotropin-releasing hormone up-regulates monocytic HLA-DR (mHLA-DR) expression.•Proopiomelanocortin peptides do not up-regulate mHLA-DR expression.•α-MSH, an anti-inflammatory peptide, is also released by monocytes.•The loss of mHLA-DR expression correlates with the loss of monocytic α-MSH release. Little is known about interactions between immune and neuro-endocrine systems in patients with septic shock. We therefore evaluated whether the corticotropin-releasing hormone (CRH) and/or proopiomelanocortin (POMC) derivatives [ACTH, β-endorphin (β-END), β-lipotropin (β-LPH), α-melanocyte stimulating hormone (α-MSH) or N-acetyl-β-END (Nac-β-END)] have any influences on monocyte deactivation as a major factor of immunosuppression under septic shock conditions. Sixteen patients with septic shock were enrolled in a double-blind, cross-over and placebo controlled clinical study; 0.5μg/(kgbodyweighth) CRH (or placebo) were intravenously administered for 24h. Using flow cytometry we investigated the immunosuppression in patients as far as related to the loss of leukocyte surface antigen-DR expression on circulating monocytes (mHLA-DR). ACTH, β-END immunoreacive material (IRM), β-LPH IRM, α-MSH and Nac-β-END IRM as well as TNF-α and mHLA-DR expression were determined before, during and after treatment with CRH (or placebo). A significant correlation between plasma concentration of α-MSH and mHLA-DR expression and an inverse correlation between mHLA-DR expression and TNF-α plasma level were found. Additionally, a significant increase of mHLA-DR expression was observed 16h after starting the CRH infusion; 8h later, the mHLA-DR expression had decreased again. Our results indicate that the up-regulation of mHLA-DR expression after CRH infusion is not dependent on the release of POMC derivatives. From the correlation between plasma concentration of α-MSH and mHLA-DR expression, we conclude that in patients with septic shock the down-regulation of mHAL-DR expression is accompanied by the loss of monocytic release of α-MSH into the cardiovascular compartment.
ISSN:0196-9781
1873-5169
DOI:10.1016/j.peptides.2013.07.013